 | • レポートコード：B-MOR-040402 • 出版社/出版日：Mordor Intelligence / 2018年3月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：医療・バイオ |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、計算生物学の世界市場について調べ、計算生物学の世界規模、市場動向、市場環境、用途別（細胞・生体組織シミュレーション、創薬・疾患モデリング、前臨床段階薬剤開発、臨床試験、人体シミュレーションソフトウェア）分析、ツール別（データベース、インフラ（ハードウェア）、分析ソフトウェア・サービス）分析、サービス別分析、エンドユーザー別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・計算生物学の世界市場インサイト ・計算生物学の世界市場環境 ・計算生物学の世界市場動向 ・計算生物学の世界市場規模 ・計算生物学の世界市場規模：用途別（細胞・生体組織シミュレーション、創薬・疾患モデリング、前臨床段階薬剤開発、臨床試験、人体シミュレーションソフトウェア） ・計算生物学の世界市場規模：ツール別（データベース、インフラ（ハードウェア）、分析ソフトウェア・サービス） ・計算生物学の世界市場規模：サービス別 ・計算生物学の世界市場規模：エンドユーザー別 ・計算生物学の世界市場：地域別市場規模・分析 ・計算生物学の北米市場規模・予測 ・計算生物学のアメリカ市場規模・予測 ・計算生物学のヨーロッパ市場規模・予測 ・計算生物学のアジア市場規模・予測 ・計算生物学の日本市場規模・予測 ・計算生物学の中国市場規模・予測 ・計算生物学のインド市場規模・予測 ・計算生物学の韓国市場規模・予測 ・関連企業情報・競争状況 |
Computational biology is defined as the application of mathematical models, theoretical methods and computer aided simulation for the study of behavioral, social and biological systems. It is an interdisciplinary field, which includes the principles of applied mathematics, computer science, statistics, genomics, genetics, animation, visualization and a lot more. It makes use of biological data to construct relationship models and algorithms between different biological systems to analyze the differences and similarities among them. The various segments of the industry include computational genomics, computational neuroscience, computational bio-modeling, computational pharmacology, evolutionary biology and cancer research. The global computational biology market is expected to register a CAGR of 19.5% during the forecast period (2018 – 2023).
Increase in Bioinformatics Research
Bioinformatics is the use of IT in biotechnology for the data storage, data warehousing and analyzing the DNA sequences. There are many applications of bioinformatics and its usage has been seen in Microbial genome applications, Molecular medicine, Personalized medicine, Preventative medicine, Gene therapy, Drug development, Antibiotic resistance, Evolutionary studies, Waste cleanup, Biotechnology and many other places. This has led to an increasing research in this field, which further requires the use of computational methods.
Also, increasing number of clinical studies in pharmacogenomics and pharmacokinetics for novel drug development and growth of drug designing, disease modeling and personalized medicine are some other drivers of the market.
Lack of Trained Professionals
Computational biology involves development and application of software, analytical and theoretical methods, mathematical modelling and other computational techniques used for study of biological, behavioral and social systems. This development and application requires use of trained professionals so as to make correct analysis. However, due to the lack of properly trained professionals hampers the market growth.
North America to Dominate the Market
The global computational biology market is segmented by drug type, therapeutic indication and geography. By geography, it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America.
North America dominates the market due to growing initiatives and investments for R&D of drug discovery, novel drugs, disease modeling, and technological advancements in biological computations.
Key Developments in the Market
• February 2018: Certara has recently acquired BaseCase, a Life Sciences Data Visualization company.
• February 2018: Schrödinger launched Cryo-EM Initiative (SCI) to develop breakthrough medicines using cryo-electron microscopy (Cryo-EM) technology.
Key players: ACCELRYS, CERTARA, CHEMICAL COMPUTING GROUP INC., COMPUGEN LTD, ENTELOS, GENEDATA AG, INSILICO BIOTECHNOLOGY AG, LEADSCOPE INC, NIMBUS DISCOVERY LLC, RHENOVIA PHARMA SAS, SCHRODINGER, SIMULATION PLUS INC among others.
Reasons to Purchase This Report
• Market analysis for the global computational biology market, with region-specific assessments and competition analysis on a global and regional scale.
• Analyzing various perspectives of the industry with the help of Porter’s five forces analysis
• The treatment type that is expected to dominate the market
• Regions that are expected to witness fastest growth during the forecast period
• Identify the latest developments, market shares and strategies employed by the major market players
• 3 months analyst support along with the Market Estimate sheet (in excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threats of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities And Challenges Analysis (Droc)
6.1 Market Drivers
6.1.1 Increase in Bioinformatics Research
6.1.2 Increasing Number of Clinical Studies in Pharmacogenomics and Pharmacokinetics
6.1.3 Growth of Drug Designing, Disease Modeling, and Personalized Medicine
6.2 Market Restraints
6.2.1 Lack of Trained Professional
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Application
7.1.1 Cellular & Biological Simulation
7.1.1.1 Computational Genomics
7.1.1.2 Computational Proteomics
7.1.1.3 Pharmacogenomics
7.1.1.4 Others (Transcriptomics/Metabolomics)
7.1.2 Drug Discovery and Disease Modelling
7.1.2.1 Target Identification
7.1.2.2 Target Validation
7.1.2.3 Lead Discovery
7.1.2.4 Lead Optimization
7.1.3 Preclinical Drug Development
7.1.3.1 Pharmacokinetics
7.1.3.2 Pharmacodynamics
7.1.4 Clinical Trials
7.1.4.1 Phase I
7.1.4.2 Phase II
7.1.4.3 Phase III
7.1.5 Human Body Simulation Software
7.2 By Tools
7.2.1 Databases
7.2.2 Infrastructure(Hardware)
7.2.3 Analysis Software & Services
7.3 By Services
7.3.1 In-House
7.3.2 Contract
7.4 By End – User
7.4.1 Academics
7.4.2 Industry
7.4.3 Commercial
7.5 By Geography
7.5.1 North America
7.5.1.1 United States
7.5.1.2 Canada
7.5.1.3 Mexico
7.5.2 Europe
7.5.2.1 France
7.5.2.2 United Kingdom
7.5.2.3 Germany
7.5.2.4 Italy
7.5.2.5 Spain
7.5.2.6 Rest of Europe
7.5.3 Asia-Pacific
7.5.3.1 India
7.5.3.2 China
7.5.3.3 Japan
7.5.3.4 Australia
7.5.3.5 South Korea
7.5.3.6 Rest of APAC
7.5.4 Middle East & Africa
7.5.4.1 GCC
7.5.4.2 South Africa
7.5.4.3 Rest of Middle East & Africa
7.5.5 South America
7.5.5.1 Brazil
7.5.5.2 Argentina
7.5.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers And Acquisition Analysis
8.2 Agreements, Collaborations & Partnerships
8.3 New Products Launches
9. Key Players
9.1 Accelrys
9.2 Certara
9.3 Chemical Computing Group Inc.
9.4 Compugen Ltd
9.5 Entelos
9.6 Genedata AG
9.7 Insilico Biotechnology AG
9.8 Leadscope Inc
9.9 Nimbus Discovery Llc
9.10 Rhenovia Pharma SAS
9.11 Schrodinger
9.12 Simulation Plus Inc
10. Future of the Market